相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ST6Gal-I Protein Expression Is Upregulated in Human Epithelial Tumors and Correlates with Stem Cell Markers in Normal Tissues and Colon Cancer Cell Lines
Amanda F. Swindall et al.
CANCER RESEARCH (2013)
Regulation of the metastatic cell phenotype by sialylated glycans
Matthew J. Schultz et al.
CANCER AND METASTASIS REVIEWS (2012)
Glycosylation, galectins and cellular signaling
Cecile Boscher et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells
Amanda F. Swindall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
ST6Gal-I Regulates Macrophage Apoptosis via α2-6 Sialylation of the TNFR1 Death Receptor
Zhongyu Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
Giovanni Luca Beretta et al.
BIOCHEMICAL PHARMACOLOGY (2010)
BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
Kerri L. Chock et al.
CANCER RESEARCH (2010)
Combination versus sequential cytotoxic chemotherapy in recurrent ovarian cancer: Time for an evidence-based comparison
Maurie Markman
GYNECOLOGIC ONCOLOGY (2010)
N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death
Lesley A. Earl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Quality control of human ABCG2 protein in the endoplasmic reticulum: Ubliquitination and proteasomal degradation
Kanako Wakabayashi-Nakao et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
Brian G. Blair et al.
CLINICAL CANCER RESEARCH (2009)
T-cell growth, cell surface organization, and the galectin-glycoprotein lattice
Ani Grigorian et al.
IMMUNOLOGICAL REVIEWS (2009)
Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling
Omai B. Garner et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system
Hiroaki Nakagawa et al.
CANCER LETTERS (2008)
Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms
Faheem M. Shaikh et al.
EXPERIMENTAL CELL RESEARCH (2008)
Sialylation of β1 Integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis
Ya Zhuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein sialylation by sialyltransferase involves radiation resistance
Minyoung Lee et al.
MOLECULAR CANCER RESEARCH (2008)
ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function
Daniel R Christie et al.
Journal of Ovarian Research (2008)
Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells
Amelie Rebillard et al.
CANCER RESEARCH (2007)
Altered mRNA expressions of sialyltransferases in ovarian cancers
PH Wang et al.
GYNECOLOGIC ONCOLOGY (2005)
Hypersialylation of β1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility
EC Seales et al.
CANCER RESEARCH (2005)
Ras oncogene induces β-galactoside α2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter
M Dalziel et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells
S Lacour et al.
CANCER RESEARCH (2004)
Ras oncogene directs expression of a differentially sialylated, functionally altered β1 integrin
EC Seales et al.
ONCOGENE (2003)
Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer
RE Merritt et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation
LT Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Sialic acid changes in Dalton's lymphoma-bearing mice after cyclophosphamide and cisplatin treatment
BM Nicol et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2002)
Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs
BAJ Jansen et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2002)
Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/CD95) death-signal pathway
JH Stewart et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2002)
Clinical correlations of α2,6-sialyltransferase expression in colorectal cancer patients
M Lise et al.
HYBRIDOMA (2000)
Cisplatin resistance and oncogene - a review
W Dempke et al.
ANTI-CANCER DRUGS (2000)
Cisplatin induces Fas expression in esophageal cancer cell lines and enhanced cytotoxicity in combination with LAK cells
I Matsuzaki et al.
ONCOLOGY (2000)
分享论文
